Does OLMESARTAN Cause Benign prostatic hyperplasia? 49 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 49 reports of Benign prostatic hyperplasia have been filed in association with OLMESARTAN. This represents 2.2% of all adverse event reports for OLMESARTAN.
49
Reports of Benign prostatic hyperplasia with OLMESARTAN
2.2%
of all OLMESARTAN reports
0
Deaths
48
Hospitalizations
How Dangerous Is Benign prostatic hyperplasia From OLMESARTAN?
Of the 49 reports, 48 (98.0%) required hospitalization, and 33 (67.3%) were considered life-threatening.
Is Benign prostatic hyperplasia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OLMESARTAN. However, 49 reports have been filed with the FAERS database.
What Other Side Effects Does OLMESARTAN Cause?
Sprue-like enteropathy (391)
Diarrhoea (313)
Gastrointestinal disorder (276)
Acute kidney injury (209)
Weight decreased (197)
Hypotension (176)
Drug ineffective (131)
Dizziness (115)
Hypokalaemia (110)
Dyspnoea (106)
What Other Drugs Cause Benign prostatic hyperplasia?
TADALAFIL (596)
TAMSULOSIN (304)
FINASTERIDE (266)
PANTOPRAZOLE (261)
PREDNISONE (257)
ALBUTEROL (254)
ASPIRIN (243)
TIOTROPIUM (235)
RAMIPRIL (193)
AMLODIPINE (179)
Which OLMESARTAN Alternatives Have Lower Benign prostatic hyperplasia Risk?
OLMESARTAN vs OLMESARTAN MEDOXOMIL
OLMESARTAN vs OLMETEC
OLMESARTAN vs OLODATEROL
OLMESARTAN vs OLODATEROL\TIOTROPIUM
OLMESARTAN vs OLOPATADINE